Parkinson's Phase 3 Study CoQ10 QE3 Treatment Report

Category: Others

false

See also: Clinical Trial

What is Parkinson's Phase 3 Study CoQ10 QE3?

An example of Parkinson's Phase 3 Study CoQ10 QE3

NCT00740714 is a a clinical trial of the effects of Coenzyme Q10 with vitamin E in Parkinson Disease. Other study IDs includes: U01NS050324, QE3.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
Evaluation/monitoring 1 1 Efficacy_none

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
0
None
1

Reported Stop Reasons

Why Patients Stopped Using Parkinson's Phase 3 Study CoQ10 QE3 (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 1   Other: 100%

See all 1 patient who’ve stopped using Parkinson's Phase 3 Study CoQ10 QE3

Stopped Using Parkinson's Phase 3 Study CoQ10 QE3

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Parkinson's Phase 3 Study CoQ10 QE3

Always
0 0%
Usually
1 100%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Parkinson's Phase 3 Study CoQ10 QE3

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%

Cost

Paid out of pocket

Cost of Parkinson's Phase 3 Study CoQ10 QE3

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

There are no evaluations for Parkinson's Phase 3 Study CoQ10 QE3 .

1 additional evaluation for Parkinson's Phase 3 Study CoQ10 QE3 is not currently shared publicly.

Last updated: